ABT vs FTK · P/E 25, rev $44.33B vs P/E 30, rev $169.4M
Abbott Laboratories (ABT) versus Flotek Industries Inc (FTK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Flotek Industries Inc (FTK) is a oil & gas equipment & services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported FTK revenue for 2026-06-30 was $169.4M. Net income was $14.6M. FTK currently screens at market cap $850.9M and trailing P/E 29.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. FTK currently screens at market cap $850.9M and trailing P/E 29.8.
Not investment advice. Open the ABT and FTK stock pages for the full models.
Not investment advice.